Living longer with letrozole? Mindful practice.(Clinical Rounds): An article from: Internal Medicine News

Femara downstaged tumors to operable size.(GYNECOLOGY): An article from: OB GYN News

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2004. The length of the article is 861 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Living longer with letrozole? Mindful practice.(Clinical Rounds)
Author: Jon O. Ebbert
Publication: Internal Medicine News (Magazine/Journal)
Date: January 15, 2004
Publisher: International Medical News Group
Volume: 37 Issue: 2 Page: 17(1)

Distributed by Thomson Gale

$5.95 - Buy This Item at Amazon.com

Other Aromatase Inhibitor Items

Breast Cancer: Risks and Prevention, Diagnosis & Treatments Breast Cancer: Risks and Prevention, Diagnosis & Treatments
Sale Price: $29.95
New Treatments for Breast Cancer New Treatments for Breast Cancer
Sale Price: $29.95
Chrysin Surge - 60 Capsules 500mg Aromatase Inhibitor Anti-estrogen Increase Testosterone Chrysin Surge - 60 Capsules 500mg Aromatase Inhibitor Anti-estrogen Increase Testosterone
Sale Price: $14.46
House Of Muscle EstroBlock -- Anti-Estrogen/Aromatase Inhibitor -- 60 Capsules House Of Muscle EstroBlock -- Anti-Estrogen/Aromatase Inhibitor -- 60 Capsules
Sale Price: $44.99
Average Rating:
CHRYSIN 500 - 60 Capsules 500mg Aromatase Inhibitor CHRYSIN 500 - 60 Capsules 500mg Aromatase Inhibitor
Sale Price: $12.93
Average Rating:
Aromatase Inhibitors: Anastrozole, Letrozole, 1,4,6-Androstatrien-3,17-Dione, Aminoglutethimide, Exemestane, Fadrozole, Atamestane, Formestane Aromatase Inhibitors: Anastrozole, Letrozole, 1,4,6-Androstatrien-3,17-Dione, Aminoglutethimide, Exemestane, Fadrozole, Atamestane, Formestane
Sale Price: $12.72

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply